Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02208102 · ClinicalTrials.gov registry record
Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation
A clinical trial, sponsored by Texas Cardiac Arrhythmia Research Foundation.
- Completed
- Registry status
- 155
- Enrollment target
NCT02208102 is a clinical trial that has completed, run by Texas Cardiac Arrhythmia Research Foundation. The registered enrollment target is 155 participants.
The verdict
NCT02208102 has completed, sponsored by Texas Cardiac Arrhythmia Research Foundation.
- COMPLETED
- Registry status
- 155 participants
- Enrollment target
Study Summary
The purpose of this study is to assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome To evaluate the inflammatory activation following catheter ablation by measuring serum-biomarker levels 24-hours after the procedure and examine the predictive role in procedure success To study the association of certain biomarkers with specific types of AF (paroxysmal or persistent or long standing persistent)
Interventions
- PROCEDURE Radio-frequency catheter ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02208102
The ClinicalTrials.gov registry entry for NCT02208102 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Cardiac Arrhythmia Research Foundation, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radio-frequency catheter ablation is the first listed.
NCT02208102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02208102 about?
NCT02208102 is a clinical study titled "Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation". The purpose of this study is to assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome To evaluate the inflammatory activation following catheter ablation by measuring serum-biomarker levels 24-hours after the procedure and examine the predictiv...
What is the current status of trial NCT02208102?
This trial is currently completed. The enrollment target is 155 participants. The study started on 2014-07. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02208102?
The interventions under investigation include: Radio-frequency catheter ablation (PROCEDURE).
Who is sponsoring clinical trial NCT02208102?
This trial is sponsored by Texas Cardiac Arrhythmia Research Foundation, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.